Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Cervical Cancer, September 2026

Free Subscription


Abstracts

Retrieve all available abstracts of the following 222 articles:
HTML format


 

Single Articles

  1. GILLES A, Stevenson E, Thompson J, McMillian-Bohler J, et al
    Enhancing Patient Participation in Follow-Up Care for Cervical Cancer Screening Abnormalities: A Cervical Health Facilitator Pilot Project.
    Nurs Womens Health. 2026 Sep 4:S1751-4851(26)00173.
    PubMed    
    Abstract available

  2. AHN C, Seo H, Jo D, Han B, et al
    Intrathecal Chemotherapy Through Ommaya Reservoir in Leptomeningeal Metastasis From Cervical Cancer: A Rare Case Report and Literature Review.
    J Obstet Gynaecol Res. 2026;52:e70490.
    PubMed    
    Abstract available

  3. NYALAMBISA A, Basera A, Xelwa N, Fadebi O, et al
    Interaction of circular RNAs with splicing factors in cervical cancer: Modulation, interplay and theranostics (Review).
    Mol Med Rep. 2026;34:295.
    PubMed    
    Abstract available

  4. ANGUYO M, Okello MO, Komakec D, Alyoomu E, et al
    Knowledge, Attitudes, and Uptake of Cervical Cancer Screening Among Female Students and Staff at a Tertiary Institution in Northern Uganda: A Cross-Sectional Study.
    Health Sci Rep. 2026;9:e73191.
    PubMed    
    Abstract available

  5. WANG X, Julaiti A, Aisikaer A, Wei H, et al
    Elevated neutrophil extracellular traps formation driven by the HPV-mediated CXCL8-CXCR1/2-ROS-p21 axis promotes the growth and metastasis of cervical cancer.
    Front Immunol. 2026;17:1861481.
    PubMed    
    Abstract available

  6. LI Y, Wang S, Mai Y, You Z, et al
    Efficacy and Safety of Immune Checkpoint Inhibitors for Recurrent or Metastatic Cervical Cancer: A Systematic Review and Meta-Analysis.
    Curr Gene Ther. 2026 Aug 22. doi: 10.2174/0115665232459323260803060556.
    PubMed    
    Abstract available

  7. KOSITAMONGKOL C, Mepramoon E, Kanchanasurakit S, Talungchit P, et al
    Perceived Feasibility and Acceptability of a Self-Collected HPV DNA Testing Policy for Cervical Cancer Screening in Thailand.
    J Prim Care Community Health. 2026;17:21501319261486985.
    PubMed    
    Abstract available

  8. ZHOU YN, Xu FJ, Yao CF, Li Y, et al
    Infection and alpha-ketoglutarate/oxygen inhibition converge to CDC20 to promote cancer cell aneuploidy.
    Signal Transduct Target Ther. 2026;11:364.
    PubMed    
    Abstract available

  9. CHEN J, Kang HY, Jiang YH, Chen CC, et al
    [Mechanism study on baicalein inhibiting cervical cancer driven by persistent HPV infection via restoring MAVS-IRF3-IFN-beta mitochondrial antiviral signal].
    Zhongguo Zhong Yao Za Zhi. 2026;51:4493-4501.
    PubMed    
    Abstract available

  10. NOREEN K, Khalid SN, Noor M, Maryam S, et al
    HPV vaccine uptake in Pakistan: A qualitative study to identify barriers and facilitators before the first HPV national rollout.
    Hum Vaccin Immunother. 2026;22:2721105.
    PubMed    
    Abstract available

  11. HEJCMANOVA K, Ngo O, Chloupkova R, Ambrozova M, et al
    Cancer screening programmes in the Czech Republic and their results.
    Klin Onkol. 2026;39.
    PubMed    
    Abstract available

  12. KOOT J, Kabukye J, Shyamala G, Nazrul N, et al
    Applying an AI Decision Support Device During Cervical Cancer Screening in Bangladesh and Uganda: Implementation Study.
    JMIR Form Res. 2026;10:e81493.
    PubMed    
    Abstract available

  13. KAREKAR AK, Kamat SK, Samant PY, Dandekar SP, et al
    Stage-specific lipidomic signatures as biomarkers in progression of cervical cancer.
    Indian J Med Res. 2026;164:349-356.
    PubMed    
    Abstract available

  14. DESHMUKH VN, Patil SR, Hinge DD, Jadhav PS, et al
    HPV genotype distribution and associated risk factors in women from Karad, Maharashtra: A molecular characterisation study.
    Indian J Med Res. 2026;164:493-495.
    PubMed    
    Abstract available

  15. AHN SY, Yu SY
    Experiences and challenges of North Korean defectors with cervical cancer: a qualitative study using thematic analysis.
    Support Care Cancer. 2026;34:926.
    PubMed    
    Abstract available

  16. GHOSH D, Verma D, Bhimsaria D, Packirisamy G, et al
    Gelatin-PVA Hydrogel Composite-Based Immunosensing Interface for Early Detection of HPV16-Driven Cervical Cancer.
    ACS Appl Bio Mater. 2026 Sep 1. doi: 10.1021/acsabm.6c01028.
    PubMed    
    Abstract available

  17. NAKAJIMA K, Yagi A, Taira K, Otsubo R, et al
    Near-peer education by medical students and its association with HPV vaccination knowledge and attitudes among Japanese adolescents: An exploratory intervention study.
    Hum Vaccin Immunother. 2026;22:2724650.
    PubMed    
    Abstract available

  18. RATHWELL M, Dolin A, Bandara T, Halligan M, et al
    Can we eliminate cervical cancer in Canada? In conversation with leading experts in public health and cancer prevention.
    Can J Public Health. 2026 Sep 2. doi: 10.17269/s41997-026-01247.
    PubMed    


  19. DERESE BD, Kantelhardt EJ, Frese T, Ferrell B, et al
    Supportive care needs among patients with breast and cervical cancer at a tertiary cancer treatment center in ethiopia: a cross-sectional study.
    Sci Rep. 2026;16:27555.
    PubMed    
    Abstract available

  20. GUEVARA H, Hcini N, Virjoghe B, Wankpo B, et al
    Cervical cancer in French Guiana before the implementation of the University Hospital: Outcome and prognosis.
    Bull Cancer. 2026 Sep 2:S0007-4551(26)00397-8. doi: 10.1016/j.bulcan.2026.
    PubMed    
    Abstract available

  21. FRANK A, Correa-Mendez M, Livinski AA, Duncan K, et al
    Understanding the association between immune-modulating helminths and HPV or cervical cancer: A scoping review.
    PLoS Negl Trop Dis. 2026;20:e0013308.
    PubMed    
    Abstract available

  22. LI B, Li S, Tan Z, Lin X, et al
    Identification of Risk Factors and Development of a Prediction Model for Postoperative Urinary Retention Following Radical Hysterectomy for Cervical Cancer Based on Preoperative Urodynamic Profiling.
    Arch Esp Urol. 2026;79:1162-1170.
    PubMed    
    Abstract available

  23. MOSQUERA I, Tisler A, Ramirez AT, Elfstrom KM, et al
    Assessing the Capacity of Health Facilities to Deliver Concomitant HPV Vaccination and HPV-Based Cervical Screening Services to Vulnerable Populations - An Implementation Research Protocol.
    Cancer Control. 2026;33:10732748261475365.
    PubMed    
    Abstract available

  24. WU Y, Xue X, Su L, Liu Y, et al
    Correction: Effect of bladder volume on dose of exposure to dangerous organs and incidence of cystitis and enteritis in patients with cervical cancer after external radiotherapy.
    Front Oncol. 2026;16:1959912.
    PubMed    
    Abstract available

  25. LIU H, Wang D, Tang J, Wang C, et al
    Serplulimab combined with bevacizumab and chemotherapy as first-line treatment for recurrent or metastatic cervical cancer (ASTRUM-CC01): a phase II trial.
    Front Immunol. 2026;17:1923961.
    PubMed    
    Abstract available

  26. LIU X, Zheng J, Zhang C, Shi X, et al
    Real-world efficacy and safety profile of low-dose cadonilimab in recurrent or metastatic cervical cancer as first-line therapy.
    Front Immunol. 2026;17:1871890.
    PubMed    
    Abstract available

  27. MENGISTIE N, Verma H, Bozzon A, Bramer WM, et al
    Access to cervical cancer care in sub-Saharan Africa: a narrative review of barriers and opportunities.
    Front Public Health. 2026;14:1881652.
    PubMed    
    Abstract available

  28. WANG H, Zhang G, Wang S, Kong Y, et al
    Virtual MR elastography and continuous-time random walk for predicting Ki-67 status in cervical cancer: a preliminary study.
    Front Oncol. 2026;16:1843126.
    PubMed    
    Abstract available

  29. ZHANG L, Quan R, Huang H, Wang W, et al
    ERalpha36 is associated with SLC7A5/LAT1 expression, cervical cancer progression, and BNCT response: a translational study.
    Front Oncol. 2026;16:1902977.
    PubMed    
    Abstract available

  30. XU Y, Zhou X, Guo L, Lyu R, et al
    DNA Methylation Testing in Cervical Cancer: A Triage Tool for HPV-Based Screening and Post-Treatment Surveillance.
    J Obstet Gynaecol Res. 2026;52:e70473.
    PubMed    
    Abstract available

  31. LIN X, Wang Y, Yu N, Wang D, et al
    HPV Integration as a Triage Tool for HPV-Positive Women in Cervical Cancer Screening.
    Tumour Virus Res. 2026 Sep 1:200351. doi: 10.1016/j.tvr.2026.200351.
    PubMed    
    Abstract available

  32. LI X, Liu X, Ma G, Wang L, et al
    Guardians' willingness to vaccinate primary and secondary school girls against human papillomavirus and associated factors in ethnic autonomous prefectures of Qinghai Province, China: A cross-sectional study based on the Health Belief Model and Theory
    Hum Vaccin Immunother. 2026;22:2725492.
    PubMed    
    Abstract available

  33. MOODALEY P, Lim K, Do V, Descallar J, et al
    Volumetric and Geometric Assessment of Offline Adaptation in Cervical Cancer External Beam Radiotherapy.
    J Med Imaging Radiat Oncol. 2026 Sep 1. doi: 10.1111/1754-9485.70171.
    PubMed    
    Abstract available

  34. AKANNI OA, Yakubu IM, Ojurongbe AO, Fijabiye MO, et al
    Cervical Cancer Screening Utilization and Its Correlates Among Women of Reproductive Age in North Central Nigeria: A Cross-Sectional Study.
    Niger Med J. 2026;67:1463-1472.
    PubMed    
    Abstract available

  35. YANG J, He Q, Peng J, Wang Y, et al
    Artificial intelligence-assisted histopathological diagnosis of endocervical gastric-type adenocarcinoma: a multicenter model development and validation study.
    J Pathol Clin Res. 2026;12:e70113.
    PubMed    
    Abstract available

  36. ZHANG H, Liu A, Zhang R, Wang Y, et al
    Development and Application of a Psychological Expectations Scale for Patients With Middle- and Late-Stage Cervical Cancer in China.
    J Obstet Gynaecol Res. 2026;52:e70481.
    PubMed    
    Abstract available

  37. VON DER BRELIE L, Kalyoncu NG, Gallwas J, Grundker C, et al
    CTGF/CCN2 Promotes Invasive Growth in Cervical Cancer Spheroids and Is Associated With Metastatic Cervical Cancer Tissue.
    Cancer Genomics Proteomics. 2026;23:934-947.
    PubMed    
    Abstract available

  38. TULI A, Jit M, Abbas K, Portnoy A, et al
    Projections of human papillomavirus (HPV) vaccination impact on non-cervical cancer outcomes among women in 117 low- and middle-income countries: a modelling study.
    BMJ Glob Health. 2026;11:e021127.
    PubMed    
    Abstract available

  39. THEODORIDIS TD, Kontovazainitis CG, Negre RR, Argay I, et al
    Complications, recurrence, and survival rates for endometrial and cervical cancer treated by minimally invasive surgery: a systematic review and meta-analysis of randomised controlled trials.
    Facts Views Vis Obgyn. 2026 Aug 31. doi: 10.52054/FVVO.2026.
    PubMed    
    Abstract available

  40. BRUNI L, Brotons M, Alvarez J, Roden RBS, et al
    Developments in human papillomavirus vaccines, schedules, and implementation strategies.
    J Natl Cancer Inst Monogr. 2026;2026:137-147.
    PubMed    
    Abstract available

  41. SIMMS KT, de Bondt D, Killen J, Sy S, et al
    Benefits, harms, and cervical cancer elimination timing of human papillomavirus screening approaches tailored to birth cohort as a proxy for vaccination status in the United States: a comparative modeling study.
    J Natl Cancer Inst Monogr. 2026;2026:126-136.
    PubMed    
    Abstract available

  42. ADSUL P, Adcock R
    From evidence to practice: leveraging implementation science for transitioning to risk-adapted cervical cancer screening.
    J Natl Cancer Inst Monogr. 2026;2026:194-203.
    PubMed    
    Abstract available

  43. ALMONTE M, Tejada RA, Calderon A, Baena A, et al
    Cervical cancer screening in vaccinated populations: challenges and implications for low- and middle-income countries.
    J Natl Cancer Inst Monogr. 2026;2026:155-163.
    PubMed    
    Abstract available

  44. BONDE J, Castle PE
    Deintensification of cervical cancer screening in the era of high human papillomavirus-vaccination coverage.
    J Natl Cancer Inst Monogr. 2026;2026:173-179.
    PubMed    
    Abstract available

  45. WENTZENSEN N, Arbyn M, Poljak M
    How to evaluate and select cervical screening and triage tests in vaccinated populations.
    J Natl Cancer Inst Monogr. 2026;2026:164-172.
    PubMed    
    Abstract available

  46. BASU P, Lucas E, Elfstrom KM
    How practically feasible is tailored screening for cervical cancer based on human papillomavirus vaccination status?: the role of data linkage and registers.
    J Natl Cancer Inst Monogr. 2026;2026:180-186.
    PubMed    
    Abstract available

  47. WALLER J, Marlow L
    Effective communications to support risk-adapted cervical screening in human papillomavirus-vaccinated women: lessons learned and ways forward.
    J Natl Cancer Inst Monogr. 2026;2026:187-193.
    PubMed    
    Abstract available

  48. EL-ZEIN M, Franco EL
    The need to change cervical cancer screening in the post-human papillomavirus vaccination era: the interplay between disease prevalence and risk, test characteristics, and efficiency of screening programs.
    J Natl Cancer Inst Monogr. 2026;2026:118-125.
    PubMed    
    Abstract available

  49. GRAY P, Louvanto K
    Evidence for type replacement as a consequence of vaccination and implications for cervical screening.
    J Natl Cancer Inst Monogr. 2026;2026:148-154.
    PubMed    
    Abstract available

  50. DE AZEVEDO VR, Guimaraes IDS, Farrapo MJS, Martins-Cardoso K, et al
    EGFR and PGE2 signaling pathways mutually cooperate to promote pro-tumorigenic effects in cervical cancer.
    Biochim Biophys Acta Mol Basis Dis. 2026;1873:168443.
    PubMed    
    Abstract available

  51. HAO S, Yang S, Zhao Q, Jiang L, et al
    Charting host structural variations in cervical cancer by long-read sequencing pinpoints a functional deletion in PIAS1.
    Genomics. 2026;118:111311.
    PubMed    
    Abstract available

  52. WU T, Lv B, Wang H, He G, et al
    Harnessing necroptosis via RIPK1 degradation to potentiate radio-immunotherapy in cervical cancer.
    Bioact Mater. 2026;67:703-718.
    PubMed    
    Abstract available

  53. OZKAYA UCAR Y, Turan T
    Postoperative Sexual Quality of Life and Associated Factors After Loop Electrosurgical Excision Procedure Versus Cold Knife Conization in 185 Sexually Active Women With Preinvasive Cervical Lesions.
    Med Sci Monit. 2026;32:e954246.
    PubMed    
    Abstract available

  54. GHOLAMI FASHKHAMI M, Habibollahi H, Shafighi ST
    Chrysin treatment is associated with altered microrna expression and reduced levels of HPV16 E6 protein in caski cervical cancer cells.
    Med Oncol. 2026;43:257.
    PubMed    
    Abstract available

  55. RAO S, Chhabra M, Kudkuli J, Toraskar M, et al
    Integrating a "see-and-treat" approach with opportunistic human papilloma virus deoxyribonucleic acid (HPV DNA) based cervical cancer screening in India: a retrospective cross-sectional study.
    AJOG Glob Rep. 2026;6:100678.
    PubMed    
    Abstract available

  56. ZHENG Y, Li Y, Zhang S, Lv Q, et al
    Transcriptomics and single-cell RNA sequencing uncover prognostic characteristics and immune regulatory mechanisms of lactylation in cervical cancer.
    Bioimpacts. 2026;16:33527.
    PubMed    
    Abstract available

  57. IBITOYE OF, Muliira JK, Lazarus ER, Anyango JF, et al
    Nurse-led interventions for cervical cancer patients: A scoping review with an emphasis on East Asian contexts.
    Belitung Nurs J. 2026;12:424-437.
    PubMed    
    Abstract available

  58. WANG W, Yu T
    The implications and mechanisms of vaginal microbiota metabolites on cervical cancer progression.
    Front Cell Infect Microbiol. 2026;16:1886165.
    PubMed    
    Abstract available

  59. HUANG Q, Zhang LY, Shu HL, Chen N, et al
    Cervical cancer patients' vaginal microbiome and metabolites: research progress and clinical applications.
    Front Microbiol. 2026;17:1891111.
    PubMed    
    Abstract available

  60. CHALIF J, Morton M, McLaughlin E, Fulton J, et al
    Prognostic value of the nutritional risk index and prognostic nutritional index for immunotherapy outcomes in cervical Cancer.
    Gynecol Oncol Rep. 2026;67:102184.
    PubMed    
    Abstract available

  61. LI X, Fan X, Chai T, Hu L, et al
    HPV52 predominates in cervical infections and precancerous lesions in Chongqing, China: a 6-year study linking genotypes to vaginal microecology.
    Front Public Health. 2026;14:1879232.
    PubMed    
    Abstract available

  62. DIAW AM, Diongue FB, Ndiaye I, Gassama O, et al
    Women's autonomy and discrimination relevant to cervical cancer screening.
    Front Reprod Health. 2026;8:1837034.
    PubMed    
    Abstract available

  63. MIAO S, Guan W, Jiang W, Zhang B, et al
    High diagnostic concordance between vulvar and cervical samples for human papillomavirus detection: a cross-sectional study.
    Microbiol Spectr. 2026;14:e0402625.
    PubMed    
    Abstract available

  64. JIA Q, Li M, Liu J, Xu T, et al
    CLCF1-ZIC5-CNTFR feedback loop drives cisplatin resistance in cervical squamous cell carcinoma.
    Neoplasia. 2026;80:101342.
    PubMed    
    Abstract available

  65. GONG J, Dong S, Sun J, Cong M, et al
    Effects of a Message-Framing Video Intervention on Maternal Vaccine Confidence Regarding HPV Vaccination for Daughters: A Quasi-Experimental Study Among Mothers With Cervical Intraepithelial Neoplasia.
    Public Health Nurs. 2026;43:1316-1325.
    PubMed    
    Abstract available

  66. ERSOY E, Gursoy A, Guder H
    Evaluating the cost-effectiveness of implementing HPV vaccination in Turkiye's National Immunization Program using the PRIME model.
    Ginekol Pol. 2026;97:641-646.
    PubMed    
    Abstract available

  67. FELDMAN C, Semprini J
    Causal inference, cancer registry data, and a single state policy change: Evaluating Virginia's HPV vaccine mandate.
    J Cancer Policy. 2026;49:100777.
    PubMed    
    Abstract available

  68. BRUNEAU N, Balanda M, Martin HS, Munoz T, et al
    The prevalence of human papillomavirus infection among women in primary health care, Santiago, Chile (2015-2024).
    J Cancer Policy. 2026;49:100776.
    PubMed    
    Abstract available

  69. ABOUL-ENEIN BH, Kelly PJ, Almoayad F, Keller T, et al
    Promoting the HPV vaccine across the league of Arab states: A scoping review of interventions.
    J Cancer Policy. 2026;49:100770.
    PubMed    
    Abstract available

  70. GAO T, Kabila PM, Chiuri K, Tumba AM, et al
    Costs of HPV vaccination programs in low- and middle-income countries: A systematic review.
    J Cancer Policy. 2026;49:100767.
    PubMed    
    Abstract available

  71. CROCKER RM, Schneider JL, Rivelli JS, Gautom P, et al
    Comparative Analysis of Breast and Cervical Screening Adaptability at a Federally Qualified Health Center.
    Cancer Prev Res (Phila). 2026;19:529-540.
    PubMed    
    Abstract available

  72. KURT GUVEN H, Tunc T, Celik Inaltun CB, Asker L, et al
    The Effect of Breastfeeding on Cervical Dysplasias.
    Breastfeed Med. 2026;21:541-547.
    PubMed    
    Abstract available

  73. EJAZ M, Khan MS, Baig AQ, Hussain S, et al
    Dosimetric Comparison of Fixed-Configuration Versus Image Guided Needle Insertion in Cervical Brachytherapy.
    Pract Radiat Oncol. 2026;16:e427-e434.
    PubMed    
    Abstract available

  74. WOODRUFF JAMESON A, Kelley C, Westmark D, Willett S, et al
    Interventions to increase cervical screening rates for women with intellectual and developmental disabilities: a scoping review.
    J Intellect Dev Disabil. 2026;51:350-360.
    PubMed    
    Abstract available

  75. NICHOL B, Bryant A, Hall L, von Wagner C, et al
    Behaviourally informed text message reminders to increase cervical screening attendance in people with severe mental illness: the OPTIMISE pilot randomised controlled trial.
    BMJ Open. 2026;16:e122934.
    PubMed    
    Abstract available

  76. BAHREHMAND K, Fabian T, Kerepesi J, Novak Z, et al
    [The role of sentinel lymph node biopsy in the management of gynecologic cancers: current evidence and institutional experience].
    Magy Onkol. 2026;70:269-276.
    PubMed    
    Abstract available

  77. MODI A, Parida BP, Pradhan S, Singh S, et al
    LiCl induces GSK-3beta mediated autophagy, DNA damage, and cell cycle arrest in HPV driven cervical cancer cells.
    Cancer Chemother Pharmacol. 2026;96:99.
    PubMed    
    Abstract available

  78. EDWARDS L, Tan H, Rahim K, Leong E, et al
    MRI-Guided SBRT Boost for Patients With Locally Advanced Cervical Cancer Who Are Unsuitable for Standard of Care Image-Guided Brachytherapy.
    J Med Imaging Radiat Oncol. 2026 Sep 12. doi: 10.1111/1754-9485.70185.
    PubMed    
    Abstract available

  79. LIU S, Yang T, Chu A, Sun C, et al
    VCAN is upregulated in the cervical cancer stroma and modulates macrophage polarization.
    Front Oncol. 2026;16:1902341.
    PubMed    
    Abstract available

  80. ONISHI T, Miyamoto T, Osawa Y, Shibahara K, et al
    Dataset of multi-focus (Z-stack) images derived from liquid-based cervical cancer cytology specimens.
    F1000Res. 2026;15:502.
    PubMed    
    Abstract available

  81. KRISHNA A, Lobo JL, Ms P, Makkapati BS, et al
    Evaluation and Clinical Relevance of Plan Quality Indices in Intracavitary Brachytherapy for Cervical Cancer.
    F1000Res. 2026;14:882.
    PubMed    
    Abstract available

  82. FERRELL CD, Hall KC, Reaves S, Wentzensen N, et al
    Why Women Don't Return: Nurse Perspectives on Follow-Up Care After Abnormal Cervical Cancer Screening Results in Mississippi's Public Health System.
    Public Health Nurs. 2026 Sep 12. doi: 10.1111/phn.70186.
    PubMed    
    Abstract available

  83. SHI Y, Sherryn S, Wang S, Lei Z, et al
    Palliative Management of Inoperable Vesicovaginal Fistula in Cervical Cancer Patient Using Bilateral Single-J Stents and Bladder Stoma: A Pilot Study.
    Int Urogynecol J. 2026 Sep 11. doi: 10.1007/s00192-026-06890.
    PubMed    
    Abstract available

  84. CHIKAZAWA K, Ozawa R, Kuwata T
    Who should participate in laparoscopic surgery trials for early cervical cancer? Surgeon authority and selection bias in randomized studies of open versus minimally invasive surgery for early-stage cervical cancer.
    J Gynecol Oncol. 2026 Aug 28. doi: 10.3802/jgo.2027.
    PubMed    


  85. KANG Y, Huang Y, Chen Y, Osafo KS, et al
    Hypoxia-inducible factor-1alpha promotes the malignant progression of cervical cancer cells by regulating lactate dehydrogenase A-mediated glycolysis.
    Transl Cancer Res. 2026;15:632.
    PubMed    
    Abstract available

  86. QI T, Yang J, Abulizi G
    CEBPG demonstrates oncogene functions and modulates the expression of genes involved in cervical cancer related pathways.
    Transl Cancer Res. 2026;15:593.
    PubMed    
    Abstract available

  87. YU H, Xiu Y, Meng F, He H, et al
    A three-gene radioresistance signature predicts tumor progression in cervical cancer.
    Transl Cancer Res. 2026;15:577.
    PubMed    
    Abstract available

  88. WENG C, Wang Y, Chen W, Chen S, et al
    Survival outcomes of postoperative radiotherapy and chemotherapy in early-stage cervical cancer: a Surveillance, Epidemiology, and End Results database-based stratified analysis.
    Transl Cancer Res. 2026;15:572.
    PubMed    
    Abstract available

  89. GUO L, Li C, Guo J, Qiu J, et al
    Erratum: CKAP2 promotes cervical cancer progression by modulating the tumor microenvironment via NF-kappaB signaling.
    Am J Cancer Res. 2026;16:3750-3752.
    PubMed    
    Abstract available

  90. SUBANDI S, Aisyah ON, Lestari B
    Nanoliposomal curcumin as a potential pro-apoptotic agent for cervical cancer: Evidence from Bcl-2 and Bax modulation in HeLa cells.
    Narra J. 2026;6:e3126.
    PubMed    
    Abstract available

  91. BABAIE M, Aghili M, Poudineh M, Bayani R, et al
    Short course versus conventional interventional radiotherapy (brachytherapy) regimen in locally advanced cervical cancer: A randomized clinical trial.
    Brachytherapy. 2026 Sep 10:S1538-4721(26)00268.
    PubMed    
    Abstract available

  92. BILAN F, Jafari B, Gharesouran J, Kiani Darabi AH, et al
    Long non-coding RNAs as biomarkers for diagnosis and prognosis in HPV-associated cervical cancer: A systematic scoping review.
    Cancer Treat Res Commun. 2026;49:101437.
    PubMed    
    Abstract available

  93. HASEGAWA K, Colombo N, Tewari KS, Dubot C, et al
    Pembrolizumab Plus Chemotherapy for Cervical Cancer: An Exploratory Analysis of the KEYNOTE-826 Randomized Clinical Trial.
    JAMA Oncol. 2026 Sep 10:e263547. doi: 10.1001/jamaoncol.2026.3547.
    PubMed    
    Abstract available

  94. CEESAY E, Avala Ntsigouaye J, Onwuka JU, Shanshan Y, et al
    Integrating Cervical Cancer Prevention into HIV Services in Sub-Saharan Africa: A Narrative Review Addressing the Dual Burden Among Women.
    Open Forum Infect Dis. 2026;13:ofag509.
    PubMed    
    Abstract available

  95. RAHMAN MA, Bhuiyan MTA, Khan MFI, Uddin MZ, et al
    Integrating domain-specific convolutional features with Swin Transformers for transparent cervical cancer diagnostics.
    Front Oncol. 2026;16:1878677.
    PubMed    
    Abstract available

  96. WANG K, Ma X, Wang H
    A latent profile analysis of the pain-fatigue-sleep disturbance symptom clusters in postoperative cervical cancer patients: a multicenter cross-sectional study.
    Front Public Health. 2026;14:1901928.
    PubMed    
    Abstract available

  97. NDOUR AA, Malham SA, Milot DM, Baron G, et al
    Barriers and Facilitators to the Implementation of the Weekend-70 Cervical Cancer Screening Programme in Mali: A Multiple Case Study.
    Int J Health Plann Manage. 2026 Sep 9. doi: 10.1002/hpm.70136.
    PubMed    
    Abstract available

  98. RANI VV, Vasavi G, Reddy KVSP
    Comment on "Radiomics-based machine-learning approach to predict response at brachytherapy using pretreatment magnetic resonance imaging in locally advanced cervical cancer".
    Brachytherapy. 2026;25:882-883.
    PubMed    


  99. WANG W, Shayilan N, Qi X, Ma C, et al
    Design, synthesis, and screening of novel thienopyrimidine derivatives as PI3K/HDAC dual inhibitors against cervical cancer cells.
    Eur J Med Chem. 2026;320:119315.
    PubMed    
    Abstract available

  100. LIN YC, Hume E, Boxtha C, Commaroto SA, et al
    Predictors of anal and cervical cancer screening uptake among adults with and without HIV: survey of a community-based health clinic network.
    Cancer Causes Control. 2026;37:159.
    PubMed    
    Abstract available

  101. PUNGARTNIK PC, Parellada CI, Mayumi Usuda Prado Rocha D, Queijo RG, et al
    Premature mortality and years of potential productive life lost due to HPV-attributable cancers in Brazil and Mexico: 2011 Versus 2023.
    Hum Vaccin Immunother. 2026;22:2728247.
    PubMed    
    Abstract available

  102. VAN ARSDALE AR, Meshcheryakova O, Gallego S, Maggi EC, et al
    Serum, cell-free, HPV-human DNA junction detection and HPV typing for predicting and monitoring cervical cancer recurrence.
    Elife. 2026;14:RP105741.
    PubMed    
    Abstract available

  103. SCHELLEKENS HCJ, Bindels BJR, Regueiro Zapico I, Morre SA, et al
    Microbiome-host interactions in locally advanced cervical cancer: the impact on chemoradiotherapy treatment outcomes and toxicity.
    Front Immunol. 2026;17:1876914.
    PubMed    
    Abstract available

  104. LIU Y, Zhao K, Sun W, Jiang N, et al
    Limited discriminant validity of health belief and 3C models in high HPV vaccine coverage settings: the moderating role of hukou and structural barriers.
    Front Public Health. 2026;14:1903410.
    PubMed    
    Abstract available

  105. CHLALA W, Favier A, Carcopino X, Canlorbe G, et al
    INITIAL EVALUATION OF CERVICAL CANCER: A LITERATURE REVIEW OF STAGING CONIZATION FOR ACCURATE RISK STRATIFICATION AND GUIDANCE OF PRIMARY TREATMENT IN EARLY-STAGE DISEASE - A REVIEW FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
    J Gynecol Obstet Hum Reprod. 2026 Sep 8:103274. doi: 10.1016/j.jogoh.2026.103274
    PubMed    
    Abstract available

  106. WU A, Rezhake R, Huang Z, Abulizi G, et al
    Association of regional lymph node resection with survival in patients with locally advanced-stage cervical cancer: A retrospective SEER-based cohort study.
    Sci Prog. 2026;109:368504261481941.
    PubMed    
    Abstract available

  107. YORDANOV AD, Tsoneva E, Dimitrova PD, Kostov SG, et al
    Unsupervised 20-feature immunohistochemical immune profiling identifies exploratory cervical cancer phenotypes with unfavorable survival signals.
    Front Oncol. 2026;16:1914836.
    PubMed    
    Abstract available

  108. TIAN Y, Chang H, Liu J, Ding W, et al
    Building bridges to immunotherapy: a knowledge-mapping analysis of cervical cancer organoid research.
    Front Immunol. 2026;17:1788725.
    PubMed    
    Abstract available

  109. HAN B, Liang M, Qi D, Qu Y, et al
    Brucea javanica oil emulsion as an adjunct to chemoradiotherapy in cervical cancer: a systematic review and meta-analysis of adverse effects reduction and immune enhancement.
    Oncol Rev. 2026;20:1880668.
    PubMed    
    Abstract available

  110. TSOGTGEREL NE, Adiyadorj D, Ganbaatar GE, Parry AE, et al
    Trends in cervical cancer incidence and mortality in Mongolia, 2014-2024: a population-based analysis of pandemic-related disruptions.
    Front Oncol. 2026;16:1853617.
    PubMed    
    Abstract available

  111. TASTAN M, Ersoy Sen B, Yilmaz M
    Factors affecting women's participation in cervical cancer screening through the theory of planned behavior: a cross- sectional study in Turkiye.
    Front Med (Lausanne). 2026;13:1910126.
    PubMed    
    Abstract available

  112. SHIMIZU A, Chikazawa K, Fukuda Y, Imai K, et al
    Real-World Outcomes of Weekly Paclitaxel-Carboplatin-Based Chemoradiotherapy Versus Cisplatin-Based Chemoradiotherapy for FIGO Stage IB2-IVA Cervical cancer: A Retrospective Observational Study.
    J Obstet Gynaecol Res. 2026;52:e70489.
    PubMed    
    Abstract available

  113. CHEN F, Ruan HJ, Chen XY, Wang Y, et al
    [Efficacy and safety of hexaminolevulinate photodynamic therapy for CIN2].
    Zhonghua Fu Chan Ke Za Zhi. 2026;61:649-657.
    PubMed    
    Abstract available

  114. ZHANG Y, Li W, Zhuo Q, Abuduwufu S, et al
    GMPS promotes cervical squamous cell carcinoma cell immune evasion through USP7-mediated deubiquitination of PDL1.
    Hum Cell. 2026;39:135.
    PubMed    
    Abstract available

  115. ANGHEL B, Manea E, Scripcariu V, Georgescu TF, et al
    Vaginal Morbidity and Quality of Life after CT-Guided Hybrid Brachytherapy for Locally Advanced Cervical Cancer.
    Chirurgia (Bucur). 2026;121:423-431.
    PubMed    
    Abstract available

  116. LUBANGA AF, Nyasulu W, Stande M, Kamanga M, et al
    Protect her future: Lessons learned from a school and community engagement initiative for HPV vaccine awareness in Lilongwe, Malawi.
    Hum Vaccin Immunother. 2026;22:2727812.
    PubMed    
    Abstract available

  117. BAI L, Li F, Liu S, Shi F, et al
    Hyperthermia sensitizes cervical cancer to chemoradiotherapy by downregulating c-Myc/WSB1/beta-catenin expression.
    Int J Hyperthermia. 2026;43:2713197.
    PubMed    
    Abstract available

  118. ROBINSON EW, Murphy EA, Albanez A, Tulsyan S, et al
    STK11 Mutations and Deletions Define an Aggressive Molecular Subgroup of Cervical Adenocarcinoma.
    Cancer Med. 2026;15:e72228.
    PubMed    
    Abstract available

  119. CHENG T, Deng L, Liang Z, Tang D, et al
    HAR-Net: Automatic delineation of clinical target volumes for cervical cancer guided by hierarchical anatomical refinement.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2026;51:1077-1097.
    PubMed    
    Abstract available

  120. FRANS SO, Utomo A, Bennett LR
    Exploring Indonesian midwives' training experiences and knowledge related to cervical screening and HPV DNA testing in East Nusa Tenggara province.
    Womens Health (Lond). 2026;22:17455057261487155.
    PubMed    
    Abstract available

  121. DAS P, Deepthi GV, Chevireddy P, Subramanian BV, et al
    Prospective Assessment of Short-Term Response and Acute Toxicity With Accelerated Fractionation Radiotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer.
    Cureus. 2026;18:e114053.
    PubMed    
    Abstract available

  122. NEETHLING GS, Razack R, Botha MHH
    From Pap Test to Treatment: Assessing Facility Level Gaps in Cervical Cancer Care in Cape Town.
    Public Health Chall. 2026;5:e70360.
    PubMed    
    Abstract available

  123. LI M, Zhang T, Shen Z, Zhang X, et al
    Molecular epidemiology and phylogeographic architecture of oncogenic intracellular bacteria in cervical cancer patients across Northern China.
    Infect Genet Evol. 2026;144:106016.
    PubMed    
    Abstract available

  124. MA C, Yin P, Hong N
    Long-term trends and future projections of cervical cancer burden in China, 1990-2023: a Global Burden of Disease 2023 analysis.
    J Gynecol Oncol. 2026 Aug 24. doi: 10.3802/jgo.2027.
    PubMed    
    Abstract available

  125. DILLNER J
    Optimising Human Papillomavirus Vaccination Strategies for Faster Cervical Cancer Elimination.
    Acta Paediatr. 2026 Sep 5. doi: 10.1111/apa.70756.
    PubMed    
    Abstract available

  126. BAFFOUR AWUAH G, Fett S, Schauberger G, Osmani V, et al
    The effect of HPV vaccination on precancerous lesions and invasive cervical cancer in a low-vaccination-coverage setting in Germany: a retrospective cohort analysis.
    Lancet Reg Health Eur. 2026;69:101830.
    PubMed    
    Abstract available

  127. YAMAZAKI H, Yamamoto S, Sakai T, Hanazono K, et al
    Primary vaginal T-cell lymphoma involving the cervix in 2 dogs.
    Can Vet J. 2026;67:982-989.
    PubMed    
    Abstract available

  128. TOSKA A, Georga D, Latsou D, Fradelos EC, et al
    Preliminary Validation of the Greek Version of the Cervical Cancer Prevention Knowledge (CCKP) Questionnaire.
    Cureus. 2026;18:e113985.
    PubMed    
    Abstract available

  129. ZOU Y, Huang R, Qin W, Wu C, et al
    Pre-radiotherapy modified prognostic nutritional index predicts acute radiation enteritis in patients with cervical cancer undergoing radiotherapy: A retrospective study.
    Oncol Lett. 2026;32:471.
    PubMed    
    Abstract available

  130. HORAMEE STA, Hosseini M, Arabpour M, Modarressi MH, et al
    Diagnostic Accuracy of DNA Methylation Markers for Detecting Cervical Precancer and Cervical Cancer: A Systematic Review and Meta-analysis.
    Arch Acad Emerg Med. 2026;14:e37.
    PubMed    
    Abstract available

  131. CHEGE MN, Kang'ethe S, Kimani SN
    Evaluation of visual inspection with acetic acid and Pap smear tests in early cervical cancer screening among women in Meru County, Kenya.
    Afr J Lab Med. 2026;15:3054.
    PubMed    
    Abstract available

  132. ARNHOLDT M, Awakowicz L, Kogelheide B, Boddecker A, et al
    Preclinical Characterization of Dielectric Barrier Discharge as a Complementary Plasma Technology for Low-Thermal Argon Plasma Devitalization of Cervical Intraepithelial Neoplasia.
    ACS Appl Mater Interfaces. 2026;18:47542-47554.
    PubMed    
    Abstract available

  133. ROTTERDAM GFS, Campelo SM, Laurentino RV, Carneiro SR, et al
    High prevalence of HPV and high levels of oxidative stress in asymptomatic mature women in the Amazon: a pilot study.
    Diagn Microbiol Infect Dis. 2026;116:117620.
    PubMed    
    Abstract available

  134. PAVIA G, Quirino A, Marascio N, Licata F, et al
    Human papillomavirus (HPV) Vaccination programmes across European countries: time-harmonized coverage among adolescent females, socioeconomic predictors, and impact on public interest.
    Vaccine. 2026;91:129058.
    PubMed    
    Abstract available

  135. WANG H, Ma H, Li R, Wang M, et al
    From human papillomavirus (HPV) infection to HPV-associated cancers in systemic lupus erythematosus: A systematic review and Meta-analysis.
    Prev Med. 2026;212:108641.
    PubMed    
    Abstract available

  136. WHITE EA
    Lightning doesn't strike twice in HPV-positive adenosquamous carcinoma.
    Trends Cancer. 2026;12:796-797.
    PubMed    
    Abstract available

  137. ADEWOLE IE, Akinsolu FT, Abodunrin OR, Lukwa AT, et al
    HPV vaccine awareness, perceptions, uptake, and school-based information channels during Nigeria's national rollout: a cross-sectional study among adolescent girls in rural Oyo State.
    BMC Public Health. 2026;26:2579.
    PubMed    
    Abstract available

  138. GENG T, Li S, Bian Y, Li X, et al
    Association of PAX1/JAM3 gene methylation, HR-HPV, and TCT with high-grade cervical lesions in a high-risk cohort: a multinomial logistic regression analysis.
    BMC Womens Health. 2026;26:447.
    PubMed    
    Abstract available

  139. KIGONGO E, Heaney C, McBride L, Gliga G, et al
    A global scoping review of interventions to increase participation in screening programmes for breast, cervical and colorectal cancer between 2016 and 2025.
    BMC Public Health. 2026;26:2549.
    PubMed    
    Abstract available

  140. BAHMAD HF
    Challenges in Assessing Stromal Invasion and Staging Cervical Carcinomas Arising In or Confined to Endocervical Polyps.
    Int J Surg Pathol. 2026;34:1701-1712.
    PubMed    
    Abstract available

  141. BAJWA HK, Beriwal S, Natte R, Sherin R, et al
    Outcomes of single application and three fraction hybrid MR adaptive brachytherapy in Carcinoma Cervix-Early experience from an Indian cancer center.
    Brachytherapy. 2026;25:736-740.
    PubMed    
    Abstract available

  142. ZHENG P, Chen W, Jiang M
    Psychiatric disorders and gynecologic tumors: A 2-sample Mendelian randomization study of 20 exposure-outcome pairs.
    Medicine (Baltimore). 2026;105:e50669.
    PubMed    
    Abstract available

  143. QI L, Wu Y, Luo M
    Meta-analysis of PAX1/JAM3 methylation performance in high-risk HPV-positive women.
    Medicine (Baltimore). 2026;105:e50757.
    PubMed    
    Abstract available

  144. MARKUS M, Sartor H, Bjurberg M, Minarik D, et al
    FDG-PET/CT-based treatment response predicts recurrence and overall survival in locally advanced cervical cancer.
    BMC Med Imaging. 2026;26:458.
    PubMed    
    Abstract available

  145. LU TF, Shih YH, Lu CH
    Interpreting Long-Term Hormone Therapy Associations After Cervical Cancer Chemoradiotherapy (Reply to Letter-to-the-Editor).
    Am J Obstet Gynecol. 2026 Sep 18:S0002-9378(26)00490.
    PubMed    


  146. LI N, Yan W, Wang Z, Ren H, et al
    Targeting mitochondrial G-quadruplex DNA with a theragnostic small molecule for cervical Cancer imaging and therapy.
    Spectrochim Acta A Mol Biomol Spectrosc. 2026;365:128793.
    PubMed    
    Abstract available

  147. XIE M, Li Q
    Tissue factor-targeted antibody-drug conjugates in cervical cancer: Focus on tisotumab vedotin.
    Cancer Treat Res Commun. 2026;49:101400.
    PubMed    
    Abstract available

  148. BULAMBA RM, Nalugoda F, Miller AP, Daama A, et al
    "Even with one Man, but with many women, you can get cervical cancer": Qualitative exploration of women's perceptions and experiences of cervical cancer screening in Uganda: A community-based study.
    PLOS Glob Public Health. 2026;6:e0007256.
    PubMed    
    Abstract available

  149. ZHANG M, Hai J, Yang J, Zhang Y, et al
    Nuclear Import of E2F1 Regulated by KPNB1 is Essential for Proliferation and Invasion of Cervical Cancer Cells.
    Appl Biochem Biotechnol. 2026 Sep 18. doi: 10.1007/s12010-026-05928.
    PubMed    
    Abstract available

  150. JIA J, Wang L, Wang F
    Letter to the Editor: ADC as a non-invasive surrogate for PD-L1 in cervical cancer-addressing potential confounding and the leap to immunotherapy selection.
    Eur Radiol. 2026 Sep 18. doi: 10.1007/s00330-026-12897.
    PubMed    


  151. YANG W
    Reply to the Letter to the Editor: ADC as a non-invasive surrogate for PD-L1 in cervical cancer-addressing potential confounding and the leap to immunotherapy selection.
    Eur Radiol. 2026 Sep 18. doi: 10.1007/s00330-026-12898.
    PubMed    


  152. AMADI AI, Lawal M, Khan HTA, Japhet SL, et al
    Examining women's perspectives regarding colposcopy in the cervical cancer screening program in rural Nigeria.
    Can Oncol Nurs J. 2026;36:262-271.
    PubMed    
    Abstract available

  153. TOUNKARA FK, Sissoko A, Traore M, Diawara B, et al
    Cervical Cancer Survival in Mali: A 21-Year Retrospective Cohort Study of Trends, Determinants, and Outcomes at Gabriel Toure Teaching Hospital (2003-2024).
    Obstet Gynecol Int. 2026;2026:9966827.
    PubMed    
    Abstract available

  154. DAS K, Suryarao P
    Opportunistic Cervical Cancer Screening Using Liquid-Based Cytology in a Gynaecology Outpatient Setting: A Cross-Sectional Study.
    Int J Hematol Oncol Stem Cell Res. 2026;20:144-151.
    PubMed    
    Abstract available

  155. YANG C, Song X, Sun H, Chen M, et al
    Immune remodeling during cervical cancer chemoradiotherapy: temporal biomarkers and the timing of checkpoint blockade.
    Front Immunol. 2026;17:1947595.
    PubMed    
    Abstract available

  156. LI F, Tian X, Mei F, Du Y, et al
    The expression and clinical significance of SIRT5, H2A and TOP2A in cervical cancer.
    Front Oncol. 2026;16:1899320.
    PubMed    
    Abstract available

  157. LIN B, Huang X, Huang H, Xie K, et al
    An investigational prognostic framework for stage IVB cervical cancer based on metastatic patterns: a population-based study with exploratory external evaluation.
    Front Oncol. 2026;16:1931638.
    PubMed    
    Abstract available

  158. LI X, Qiu J, Lin T, Ye Y, et al
    Prognostic significance of pretreatment peripheral blood inflammatory biomarkers in elderly patients with locally advanced cervical cancer undergoing definitive chemoradiotherapy.
    Front Oncol. 2026;16:1935344.
    PubMed    
    Abstract available

  159. ZHANG X, Zhu T, Gao Z, Han Z, et al
    Cervical, Uterine, and Ovarian Cancers in Chinese Women Aged 55 Years and Older: Burden, Temporal Trends, Risk Attribution, and Future Projections From the Global Burden of Disease Study 2021.
    J Obstet Gynaecol Res. 2026;52:e70413.
    PubMed    
    Abstract available

  160. RUBAGUMYA F, Kwizera V, Mutetiwabo I, Adedemeji A, et al
    Decentralizing Post-Treatment Follow-Up for Cervical Cancer in Rwanda: Perspectives of Survivors and Clinicians.
    JCO Glob Oncol. 2026;12:e2600131.
    PubMed    
    Abstract available

  161. TAKAHASHI Y, Takei Y, Takadera M, Taguchi M, et al
    Clinical activity of platinum rechallenge with nedaplatin plus irinotecan in recurrent cervical cancer following prior platinum-based systemic chemotherapy: a single-center retrospective study.
    Int J Clin Oncol. 2026 Sep 17. doi: 10.1007/s10147-026-03196.
    PubMed    
    Abstract available

  162. LI N, Zhang W
    Expression of Concern: Protein kinase C beta inhibits autophagy and sensitizes cervical cancer Hela cells to cisplatin.
    Biosci Rep. 2026;46:BSR20160445.
    PubMed    


  163. ZEINALKHANI F, Kamali Hakim P, Sharifi A, Azizzadeh A, et al
    Age as a pre-operative predictor of uterine, bladder, and intestinal invasion in cervical cancer.
    Acta Radiol. 2026 Sep 16:2841851261486043. doi: 10.1177/02841851261486043.
    PubMed    
    Abstract available

  164. PAUDEL P, Sah A
    Diagnostic accuracy of menstrual blood for human papillomavirus detection in cervical cancer screening: A systematic review and meta-analysis.
    Adv Med Sci. 2026 Sep 16:S1896-1126(26)00038-6. doi: 10.1016/j.advms.2026.
    PubMed    
    Abstract available

  165. CAROBELI LR, de Freitas Meirelles LE, da Silva LMBP, Dos Santos JJ, et al
    Synergistic effects of hypericin-mediated photodynamic therapy and low-dose cisplatin on cervical cancer cells.
    J Photochem Photobiol B. 2026;284:113566.
    PubMed    
    Abstract available

  166. PONZEL N, Kolesnik P
    Validation of Ukrainian breast and cervical cancer screening questionnaire.
    Wiad Lek. 2026;79:1581-1590.
    PubMed    
    Abstract available

  167. WANG C, Li P, Wang J
    Research Progress on Biomarkers Associated with Cervical Cancer Caused by HPV Infection.
    China CDC Wkly. 2026;8:1075-1083.
    PubMed    
    Abstract available

  168. IRAKIZA PM, Gashaija A, Muhammed S, Rubuga FK, et al
    Leveraging machine learning algorithms to assess the impact of cervical cancer early detection on patients' survival.
    Front Oncol. 2026;16:1880629.
    PubMed    
    Abstract available

  169. TRIPATHI T, Kumar S, Joshi U, Chaudhary A, et al
    Psoralidin inhibits stemness-associated characteristics in cervical cancer cells via modulation of Oct4/Sox2 expression.
    Naunyn Schmiedebergs Arch Pharmacol. 2026.
    PubMed    
    Abstract available

  170. DOTO D, Shirima LJ, Mmbaga B, Kinoko D, et al
    Adherence to follow-up cervical cancer screening and its predictors among women living with HIV in Moshi municipality, Tanzania: a hospital-based retrospective cohort study (2019-2024).
    BMJ Open. 2026;16:e113748.
    PubMed    
    Abstract available

  171. REN P, Wen L, Zhang Z, Wu M, et al
    Hypoxia Response Is Associated with Reduced HPV Activity and Tumor Microenvironment Remodeling in Cervical Cancer.
    Genomics Proteomics Bioinformatics. 2026.
    PubMed    
    Abstract available

  172. FU A, Cai J, Chen R, Zou X, et al
    AGRN activates GPX4 via the Wnt/beta-catenin signaling pathway to suppress ferroptosis in cervical cancer cells.
    Brief Funct Genomics. 2026;25:elag010.
    PubMed    
    Abstract available

  173. WU X, Xu C, Shi S, Ye C, et al
    An interpretable MRI radiomics approach for preoperative prediction of lymphovascular space invasion in cervical cancer using optimal peritumoral region.
    Front Oncol. 2026;16:1859587.
    PubMed    
    Abstract available

  174. UMBETZHANOVA A, Kusniyeva A, Derbissalina G, Aigul A, et al
    Digital tools to enhance adherence to cervical cancer prevention practices: systematic review.
    Front Public Health. 2026;14:1851751.
    PubMed    
    Abstract available

  175. HE W, Luo T, Qin C, Liu X, et al
    Clinical efficacy and outcomes of enhanced recovery after surgery for laparoscopic cervical cancer.
    Biomed Rep. 2026;25:120.
    PubMed    
    Abstract available

  176. CIUHODARU M, Calin AM, Nitu BF, Cambrea CS, et al
    Veil-Based Collector Device Enabling Self-Collected Cervicovaginal Sampling for Site-of-Care Primary HPV-Based Cervical Cancer and Sexually Transmitted Infections Screening: A Pilot Feasibility Study in Romania.
    Diagnostics (Basel). 2026;16:2765.
    PubMed    
    Abstract available

  177. KIM CY, Lee SW, Chong GO, Kim JM, et al
    Diagnostic Performance of Post-Treatment F-18 FDG PET/CT for Detecting Recurrent Cervical Cancer.
    Diagnostics (Basel). 2026;16:2691.
    PubMed    
    Abstract available

  178. STANIC J, Popovic-Vukovic M, Nikic P, Sovic I, et al
    Evolving Clinicopathological Characteristics of Women with Locally Advanced Cervical Cancer Treated with Definitive Chemoradiation Before and After Implementation of Organized Cervical Cancer Screening in Serbia.
    Cancers (Basel). 2026;18:2891.
    PubMed    
    Abstract available

  179. LEE HJ, Lee B
    Impact of Post-Primary Treatment Hormone Replacement Therapy on Survival in Women with Cervical Cancer.
    Cancers (Basel). 2026;18:2841.
    PubMed    
    Abstract available

  180. KAHESA C, Gonzalez D, Samwel K, Loy D, et al
    Adequacy of Visual Inspection with Acetic Acid (VIA) in Comparison to Pap Smear for Cervical Cancer Screening in Urban and Rural Settings of Tanzania.
    Cancers (Basel). 2026;18:2811.
    PubMed    
    Abstract available

  181. MUANGWONG P, Tharavichitkul E, Chakrabandhu S, Klunklin P, et al
    Clinical Outcomes and Prognostic Factors Following Routine CT-Based Image-Guided Adaptive Brachytherapy for Cervical Cancer: A Retrospective Cohort Study.
    Cancers (Basel). 2026;18:2805.
    PubMed    
    Abstract available

  182. BOU ANTOUN N, Afshan Mahmood HT, Walker AJ, Modjtahedi H, et al
    Correction: Bou Antoun et al. Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research. Int. J. Mol. Sci. 2025, 26, 1799.
    Int J Mol Sci. 2026;27:7598.
    PubMed    
    Abstract available

  183. HE J, Sun Y, Yang Z, Xu D, et al
    Comprehensive Analysis of Cuproptosis-Related Genes According to Cancer Stage and Their Prognostic Value in Cervical Cancer.
    Int J Mol Sci. 2026;27:7730.
    PubMed    
    Abstract available

  184. MAGHIAR L, Paiusan F, Chioibas R, Neamtu AA, et al
    Cervical Cancer Screening Activity at an Accredited Centre in Romania, 2018-2025: COVID-19 Disruption, Recovery and the Transition to Primary HPV Testing.
    Healthcare (Basel). 2026;14:2850.
    PubMed    
    Abstract available

  185. MAHMOUD NSA, Hendawi NE, Khedr MA, Almegewly WH, et al
    Effect of Mindfulness-Based Social-Emotional Learning Approach on Knowledge and Anxiety Levels Regarding Cervical Cancer Prevention.
    Healthcare (Basel). 2026;14:2684.
    PubMed    
    Abstract available

  186. JIN H, Piao Z, Wen W
    Successful treatment of massive stage IIIB cervical cancer with a spindle cell component: A case report.
    Medicine (Baltimore). 2026;105:e50727.
    PubMed    
    Abstract available

  187. YANG YJ, Zhu YT, Qiu WQ, Ding HY, et al
    [Exploration of a cervical cancer prevention and treatment model in low-resource regions supported by emerging technologies].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2026;60:1555-1560.
    PubMed    
    Abstract available

  188. YUAN XH, Chen Y, Kuang ZY, Fang LY, et al
    [Analysis of the global disease burden of cervical cancer in women aged 65 years and older based on the global burden of disease database].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2026;60:1436-1446.
    PubMed    
    Abstract available

  189. FAN X, Chen L, Xu J, Zheng S, et al
    Lymphangiogenesis-related gene signature-based risk model for prognostic assessment of cervical cancer: immune-metabolic characterization and molecular subtype analysis.
    Front Genet. 2026;17:1835653.
    PubMed    
    Abstract available

  190. ESTEIRE I, Reina G, Royo M, Chiva L, et al
    Cervical cancer screening in Sub-Saharan Africa: A scoping review of test and treat and test, triage and treat approaches.
    Public Health. 2026;259:106445.
    PubMed    
    Abstract available

  191. ADEJIMI AA, Dawodu O, Soibi-Harry AP, Alabi A, et al
    Gaps in Knowledge and Practice of Cervical Cancer Screening among Primary Health Care Workers in Lagos State, Nigeria: A Cross-Sectional Study.
    F1000Res. 2026;15:629.
    PubMed    
    Abstract available

  192. STOSIC M, Molina MA, Mukhedkar D, Hassan SS, et al
    Inferred functional microbiome features are associated with clinical trajectories of low-grade cervical lesions.
    BMC Microbiol. 2026;26:802.
    PubMed    
    Abstract available

  193. BASMAJIAN K, Thai D, Gajanayake H, Khan Z, et al
    Metastatic Breast Cancer to the Cervix and Endometrium Mimicking a Primary Gynecologic Malignancy.
    Perm J. 2026;30:190-194.
    PubMed    
    Abstract available

  194. DAYANI D, Ramani N, Hage MAC, Virarkar M, et al
    Neuroendocrine Carcinoma of Cervix: Comprehensive Review of Epidemiology, Pathology, and Advanced Imaging Modalities.
    Semin Ultrasound CT MR. 2026;47:360-373.
    PubMed    
    Abstract available

  195. SHENG YR, Xiao XR, Ye YZ
    Full-term delivery in pregnancy complicated with suspected residual cervical alveolar soft part sarcoma: a case report and literature review.
    BMC Pregnancy Childbirth. 2026;26:1029.
    PubMed    
    Abstract available

  196. EVARIST MR, Kibonire RA
    Bridging the service gap: health facility challenges in HPV vaccine uptake in rural Uganda.
    BMC Womens Health. 2026;26:456.
    PubMed    
    Abstract available

  197. WANG K, Lin L, Lin H, Chen Z, et al
    Correlation analysis of bacterial vaginosis with HPV infection and different grades of cervical lesions.
    BMC Womens Health. 2026;26:453.
    PubMed    
    Abstract available

  198. KYEI GK, Kyei EK, Ansong R
    Achieving Cancer Prevention Equity: A Policy Analysis of American Cancer Society HPV Vaccination Guidelines.
    J Adv Nurs. 2026;82:9384-9398.
    PubMed    
    Abstract available

  199. XIU X, Wu Y, Li J, Lin D, et al
    Anchored random reverse primer sequencing for quantitative detection of novel gene fusions.
    Nat Biomed Eng. 2026;10:1855-1870.
    PubMed    
    Abstract available

  200. AHMED F, Bibi M, Gulfishan S, Raza A, et al
    Methodological considerations in the implementation of HPV self-sampling for cervical cancer screening.
    Acta Obstet Gynecol Scand. 2026 Sep 6:10.1111/aogs.70356.
    PubMed    


  201. VAN DE KAM L, Siebers A, Bekkers R, van Hamont D, et al
    Loss to follow-up in patients diagnosed with or treated for low- and high-grade squamous intraepithelial lesions: A comparison of general practitioner- and gynecologist-led surveillance.
    Acta Obstet Gynecol Scand. 2026 Jul 21:10.1111/aogs.70301.
    PubMed    
    Abstract available

  202. KATHOLM KK, Eriksen LK, Lycke KD, Larsen NL, et al
    Active surveillance of cervical intraepithelial neoplasia and adverse pregnancy outcomes: A register-based cohort study.
    Acta Obstet Gynecol Scand. 2026 Jul 1. doi: 10.1111/aogs.70304.
    PubMed    
    Abstract available

  203. MAZZITELLI N, Star J, Meggett K, Han X, et al
    Prevalence of breast, cervical, and colorectal cancer screening among adults according to disability type and difficulty level, United States, 2021 and 2023.
    Cancer. 2026;132:e70557.
    PubMed    
    Abstract available

  204. MASHELE S, Nethavhakone N, Mohlala M, Ayeni P, et al
    Turnaround Time Trends in Cervical Cytology Screening in South Africa, 2005-2023.
    Diagn Cytopathol. 2026;54:755-763.
    PubMed    
    Abstract available

  205. DENG L, Zheng Y, Yang F, Wang Q, et al
    Minimally invasive surgery without a uterine manipulator versus open radical hysterectomy for early-stage cervical cancer: A retrospective propensity-score-matched single-center cohort study.
    Gynecol Oncol. 2026;213:41-49.
    PubMed    
    Abstract available

  206. BEKKEVOLD T, Laake I, Feiring B, Soreng K, et al
    HPV Genotype Distribution in Cervical Cancer and High-Grade Lesions in Norway, and Early Vaccine Impact.
    Int J Cancer. 2026 Aug 28. doi: 10.1002/ijc.70712.
    PubMed    
    Abstract available

  207. MORA-SOTO N, Viveros-Carreno D, Peralta JA, Rodriguez J, et al
    Diagnostic accuracy of Chronic Kidney Disease Epidemiology Collaboration 2021 and Janowitz-estimated glomerular filtration rate for identifying renal dysfunction compared with 99mTc-DTPA in patients with locally advanced cervical cancer.
    Int J Gynecol Cancer. 2026 Aug 13:104969. doi: 10.1016/j.ijgc.2026.104969.
    PubMed    
    Abstract available

  208. JORDAN SE, Gonzalez-Martin A, Morlock R, Hubig L, et al
    Patient-reported outcomes with tisotumab vedotin versus chemotherapy in patients with recurrent or metastatic cervical cancer: post hoc analyses from the open-label, randomized, phase 3 ENGOT-cx12/GOG-3057/innovaTV 301 trial.
    Int J Gynecol Cancer. 2026 Aug 11:104947. doi: 10.1016/j.ijgc.2026.104947.
    PubMed    
    Abstract available

  209. CHEN YN, Yang XL, Zhu JW, Zhou YC, et al
    Application of small-pelvic adjuvant radiotherapy in early cervical cancer without high-risk factors after hysterectomy.
    Int J Gynecol Cancer. 2026 Aug 29:104952. doi: 10.1016/j.ijgc.2026.104952.
    PubMed    
    Abstract available

  210. PAREJA R, Heredia F, Sanchez-Diaz E, Cuello MA, et al
    FIGO/IGCS Statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions.
    Int J Gynecol Cancer. 2026;36:104946.
    PubMed    
    Abstract available

  211. ARROYO MUHR LS, Mungo C, Chatzistamatiou K, Leung SOA, et al
    International Papillomavirus Society statement on reputed treatments for human papillomavirus infection and human papillomavirus-related diseases: evidence, risks, and standards for clinical evaluation.
    Int J Gynecol Cancer. 2026;36:104950.
    PubMed    
    Abstract available

  212. KABIRIAN R, de Saint Ghislain M, Le Saux O, Mathiot L, et al
    Efficacy and safety of immune checkpoint inhibitor rechallenge in cervical and endometrial cancer: a multi-center retrospective study (RICE study).
    Int J Gynecol Cancer. 2026;36:104867.
    PubMed    
    Abstract available

  213. PLANTE M, Kwon JS, Mahner S, Cormier B, et al
    Correlation of pelvic magnetic resonance imaging with diagnostic loop electrosurgical excision procedure/cone biopsy and hysterectomy pathology: an exploratory analysis of the CX.5/SHAPE trial.
    Int J Gynecol Cancer. 2026;36:104835.
    PubMed    
    Abstract available

  214. CLARK HD, Frumovitz M, Rangel KM, Li Z, et al
    Cadonilimab for recurrent small cell neuroendocrine carcinoma of the cervix: a phase 2 study.
    Int J Gynecol Cancer. 2026;36:104860.
    PubMed    
    Abstract available

  215. LUO H, Yang M, Li J, Qiu T, et al
    Toward Optimal Fractionation Schemes in Non-uniform Radiotherapy: Exploiting Helical Tomotherapy's Thread Effect for Gynecological Cancer Treatment.
    Int J Radiat Oncol Biol Phys. 2026 Mar 24:S0360-3016(26)00508.
    PubMed    
    Abstract available

  216. BRUNO MT, Pagana A, Aiello T, Pivetti E, et al
    Is active surveillance of CIN2 always appropriate? Clinical outcomes and factors associated with progression and regression over 48 months in an HPV-positive cohort.
    BMC Cancer. 2026 Jun 22. doi: 10.1186/s12885-026-16398.
    PubMed    
    Abstract available

  217. MAI Q, Chi C, Wang X, Chen Y, et al
    Multi-omics profiling reveals sphingolipid metabolism reprogramming of tumor-conditioned MDSCs in cervical cancer.
    BMC Cancer. 2026;26:1122.
    PubMed    
    Abstract available

  218. LEMA TF
    Epidemiology of pre-cancerous cervical lesions among women in Adama, Ethiopia.
    BMC Cancer. 2026 Jun 26. doi: 10.1186/s12885-026-16413.
    PubMed    
    Abstract available

  219. MOUCHERAUD C, Fan B, Li G, Ochieng E, et al
    Understanding retention in longitudinal surveys conducted by mobile phone in lower-resource contexts: A case study from Kenya.
    PLoS One. 2026;21:e0354780.
    PubMed    
    Abstract available

  220. SPENCER ER, Winer RL, Ba S, Sy MP, et al
    Impact of menopausal status on human papillomavirus detection and cervical neoplasia in middle-aged Senegalese women.
    PLoS One. 2026;21:e0358080.
    PubMed    
    Abstract available

  221. SPRINGE L, Kivite-Urtane A, Tihomirova L, Stars I, et al
    Women's compliance with cervical cancer screening recommendations and associated barriers to participation: A cross-sectional analysis.
    PLoS One. 2026;21:e0357819.
    PubMed    
    Abstract available

  222. EFFAH K, Tekpor E, Afetor M, Amuah JE, et al
    Cervical leukoplakia in Ghana: Unveiling diagnostic challenges and informing low-resource screening strategies.
    PLoS One. 2026;21:e0345847.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum


;